BACKGROUND: Percutaneous mitral valve repair (MVR) using the Evalve MitraClip has been recently introduced as a potential alternative to surgical MVR. OBJECTIVE: To assess immediate haemodynamic changes after percutaneous MVR using right heart catheterisation. Design Single-centre longitudinal cohort study. SETTING: Tertiary referral centre. PATIENTS: Fifty consecutive non-surgical patients (age 74±14 years, EuroSCORE 26±14) with moderate to severe (3+) and severe (4+) mitral regurgitation (MR) due to functional (56%), degenerative (30%) or mixed (14%) disease were selected. INTERVENTIONS: MitraClip implantation was performed under general anaesthesia with fluoroscopy and echocardiographic guidance. Haemodynamic variables were obtained before and after MVR using standard right heart catheterisation and oximetry. MAIN OUTCOME MEASURES: Haemodynamic changes immediately before and after MVR. RESULTS: Acute procedural success (reduction in MR to grade 2+ or less) was achieved in 46 (92%) patients. Mitral valve clipping reduced mean pulmonary capillary wedge pressure (mPCWP) (from 17±7 to 12±5 mm Hg), PCWP v-wave (from 24±11 to 16±7 mm Hg) and mean pulmonary artery pressure (mPAP) (from 29±12 to 24±6 mm Hg), and increased the cardiac index (CI) (from 3.1±1.0 to 3.9±1.1 l/min/m(2)) (all p<0.05). On Cox univariate regression analysis, mPCWP, PCWP v-wave- and mPAP-changes were associated with death, open-heart surgery for MR and/or hospitalisation for heart failure on follow-up. CONCLUSION: In a heterogeneous population with predominantly functional MR, percutaneous MVR with the Evalve MitraClip system lowers mPCWP, PCWP v-wave and mPAP by 20%, 20% and 8%, respectively, and increases the CI by 32%.
BACKGROUND: Percutaneous mitral valve repair (MVR) using the Evalve MitraClip has been recently introduced as a potential alternative to surgical MVR. OBJECTIVE: To assess immediate haemodynamic changes after percutaneous MVR using right heart catheterisation. Design Single-centre longitudinal cohort study. SETTING: Tertiary referral centre. PATIENTS: Fifty consecutive non-surgical patients (age 74±14 years, EuroSCORE 26±14) with moderate to severe (3+) and severe (4+) mitral regurgitation (MR) due to functional (56%), degenerative (30%) or mixed (14%) disease were selected. INTERVENTIONS: MitraClip implantation was performed under general anaesthesia with fluoroscopy and echocardiographic guidance. Haemodynamic variables were obtained before and after MVR using standard right heart catheterisation and oximetry. MAIN OUTCOME MEASURES: Haemodynamic changes immediately before and after MVR. RESULTS: Acute procedural success (reduction in MR to grade 2+ or less) was achieved in 46 (92%) patients. Mitral valve clipping reduced mean pulmonary capillary wedge pressure (mPCWP) (from 17±7 to 12±5 mm Hg), PCWP v-wave (from 24±11 to 16±7 mm Hg) and mean pulmonary artery pressure (mPAP) (from 29±12 to 24±6 mm Hg), and increased the cardiac index (CI) (from 3.1±1.0 to 3.9±1.1 l/min/m(2)) (all p<0.05). On Cox univariate regression analysis, mPCWP, PCWP v-wave- and mPAP-changes were associated with death, open-heart surgery for MR and/or hospitalisation for heart failure on follow-up. CONCLUSION: In a heterogeneous population with predominantly functional MR, percutaneous MVR with the Evalve MitraClip system lowers mPCWP, PCWP v-wave and mPAP by 20%, 20% and 8%, respectively, and increases the CI by 32%.
Authors: Ilonka Rohm; Tudor C Poerner; Ali Hamadanchi; Sylvia Otto; Torsten Doenst; Christian Jung; P Christian Schulze; Björn Goebel Journal: Int J Cardiovasc Imaging Date: 2017-05-11 Impact factor: 2.357
Authors: Jakob Ledwoch; Jennifer Franke; Stephan Baldus; Wolfgang Schillinger; Raffi Bekeredjian; Peter Boekstegers; Ulrich Hink; Karl-Heinz Kuck; Taoufik Ouarrak; Helge Möllmann; Georg Nickenig; Jochen Senges; Olaf Franzen; Horst Sievert Journal: Clin Res Cardiol Date: 2014-06-13 Impact factor: 5.460
Authors: Poay Huan Loh; Christos V Bourantas; Pak Hei Chan; Nikolaj Ihlemann; Fin Gustafsson; Andrew L Clark; Susanna Price; Carlo Di Mario; Neil Moat; Farqad Alamgir; Rodrigo Estevez-Loureiro; Lars Søndergaard; Olaf Franzen Journal: World J Cardiol Date: 2015-11-26
Authors: Stefan Toggweiler; Michel Zuber; Daniel Sürder; Patric Biaggi; Christine Gstrein; Tiziano Moccetti; Elena Pasotti; Oliver Gaemperli; Francesco Faletra; Iveta Petrova-Slater; Jürg Grünenfelder; Peiman Jamshidi; Roberto Corti; Giovanni Pedrazzini; Thomas F Lüscher; Paul Erne Journal: Open Heart Date: 2014-04-08
Authors: Stephan Rosenkranz; J Simon R Gibbs; Rolf Wachter; Teresa De Marco; Anton Vonk-Noordegraaf; Jean-Luc Vachiéry Journal: Eur Heart J Date: 2015-10-27 Impact factor: 29.983
Authors: M Hünlich; E Lubos; B E Beuthner; M Puls; A Bleckmann; T Beißbarth; T Tichelbäcker; V Rudolph; S Baldus; U Schäfer; H Treede; R S Von Bardeleben; S Blankenberg; W Schillinger Journal: Biomed Res Int Date: 2018-03-14 Impact factor: 3.411